|
Washington
(H24N).
Prescription drug sales have escalated in recent years fueled by
drug companies’ increased spending on advertising particularly on
television, according to a recent study by the National Institute
for Health Care Management Foundation (NIHCM).
Pharmaceutical
companies spent $1.8 billion in 1999 on mass media campaigns that
market their drugs directly to consumers. That figure is up 38.5
percent from the $1.3 billion the industry spent on direct-to-consumer
advertising in 1998, and 33 times the $55 million spent on mass
media ads in 1991.
Television
ads made up most of the mass media bill, with companies spending
$1.1 billion to get the word out about their products to viewers.
Consumers
apparently got their message loud and clear. Sales for the cholesterol
drug Lipitor, for example, marketed by Warner-Lambert/Pfizer rose
almost 56 percent in 1999 to $2.6 billion. Warner-Lambert/Pfizer
spent $55.4 million to mass market Lipitor to consumers in 1999,
up from $7.8 million spent on advertising in 1998.
"A
cause-and-effect relationship between direct-to-consumer ads and
the rise in drug prescriptions and pharmaceutical spending has not
been firmly established," wrote the study’s authors. "But
many observers infer it and the circumstantial evidence is strong."
In
1997, the Food and Drug Administration (FDA) defined the rules governing
such advertising, which opened the floodgates for pharmaceutical
companies to mass market their drugs. The FDA made it easier for
companies to launch ads in print, on radio and on television.
Today,
prescription drug spending is the fastest growing health care expense,
according to the study. In 1998, retail drug stores dispensed about
2.6 billion prescriptions, up from 2.1 billion in 1994.
"Numerous
observers have raised concerns about whether mass media ads are
inappropriately inducing demand for some new prescription medicines,"
wrote the study’s authors. "They worry that people are beginning
to ask their doctors for newer and costlier medicines when less
expensive drugs may work just as well. Proponents of direct-to-consumer
advertising argue that the ads have added enormously to the information
consumers are getting about prevalent health conditions and diseases
that are widely undertreated in the United States such as heart
disease, diabetes, hypertension and depression."
|